This site is intended for healthcare professionals

CheckMate -649, a phase III trial of Opdivo + chemotherapy vs. chemotherapy, meets primary endpoints of superior overall survival and progression-free survival in first-line treatment of gastric and esophageal cancers. BMS

Read time: 1 mins
Last updated:28th Jun 2021
Published:13th Aug 2020
Condition: Gastric Cancer/Stomach Cancer
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest